NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









APrevent Medical Inc.

APrevent Medical Inc.

Private
TaipeiHealthcare & Life Scienceshttps://www.apreventmed.com/en

Last Round

Grant

Sep 9, 2024

Total Funding Raised

$10.3M

Company Overview

APrevent Medical Inc. is a medical device company that develops innovative solutions for voice and speech disorders, including an adjustable vocal implant system and a speech conversion software platform.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Vertical SaaS, NLP & Conversational AI

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

laryngeal implantvocal implantadjustable implantglottic insufficiencyunilateral vocal fold paralysisUVFPmedtechENT devicepost-operative adjustmentmedical devicespeech conversion softwarespeech AIdysarthriacommunication aidassistive technologyvoice disorderspeech disorder

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

APrevent Medical Inc. Comparables

Compare APrevent Medical Inc. with similar companies based on industry and business-model similarity.

APrevent Medical Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cytophil, Inc.
78%
Sofregen Medical
75%
Boston Medical Products, Inc.
74%

APrevent Medical Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 9, 2024
Series DMar 29, 2024
GrantNov 19, 2022

Key People

Founding team and executive leadership

Mark Chang

Co-Founder, COO And CTO

Founding Team

APrevent Medical Inc. Investors

Notable investors and investment history

APrevent Medical Inc. investors
InvestorRounds
Taiwania CapitalSeries D
MedTech InnovatorGrant
Qualcomm Innovate in Taiwan ChallengeGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 7, 2025

    Monthly visitors grew 654% MoM.

  • Mar 27, 2025

    Monthly visitors grew 69% MoM, reaching 2.7K.

APrevent Medical Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

APrevent Medical Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about APrevent Medical Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTaipei
Employee Range16
Year Founded2013
Last FundingSep 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.